We are proud to welcome you to The International Conference and Exhibition on Dual Diagnosis which is going to be held during July 18-19, 2016 in Chicago, USA with a root motif “Research strategies, advanced technologies and innovations in Dual Diagnosis” which is a cornerstone for accomplishing Addiction Rehabilitation and psychiatry problems. Dual Diagnosis 2016 will extend an opportunity for all marketing societies working on addiction and comorbid psychiatric disorders to exhibit their work.
This activity has been approved for AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC.
PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Dual Diagnosis conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Psychiatry researchers from both academic and health care professionals will join this event to discuss their views and research. The event will be organized by world addiction and psychiatry experts for conducting symposiums, B2B meetings, and workshops will also be conducted on the field of Dual Diagnosis therapy, Addiction Rehabilitation, Alcohol Rehabilitation, Addiction treatment, Dual Diagnosis treatment, Mental illness and, Psychiatric disorders.
Track 01: Drug Addiction
Addictions are chronic, deteriorate brain disorders and identified by drug seeking and abuse. Addiction changes the brain functioning. Those drugs effects human brain is much harmful, and often self-destructive. Abuse and Alcohol Rehabilitation to drugs cost Americans more than $800 billion per year. Illicit, prescription drugs and alcohol causes the death of around 90,000 Americans, while tobacco with 480,000 deaths. Addiction Rehabilitation is a central nervous system depressant; it slows down mental and bodily processes. American association of Dual Diagnosis reveals that alcohol addiction may experience a decrease in feelings of anxiety or stress.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference June 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, American Academy of Addiction Psychiatry, American Association of Directors of Psychiatric Residency Training, Association for Academic Psychiatry, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 02: Bipolar Disorders
Bipolar disorders may call as manic-depressive sickness that involves mania and depression. In such cases mood changes from low to high and back again square measure dramatic and rapid, but additional often they are gradual and slow, and intervals of normal mood may occur between the manic and depressive phases of the condition. The symptoms of depressive and manic cycles may be severe and infrequently lead to impaired functioning. In any given year, manic-depressive psychosis affects more than 2 of American adults. About 5.7 million American adults, or about 2.6 % of the population aged 18 and older, have emotional disorder.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference June 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, The Addiction Section of the Egyptian Psychiatric Association, Finnish Society of Addiction Medicine, Israeli Society of Addiction Medicine, Swiss Society of Addiction Medicine, Alcoholism and Substance Abuse Providers of New York State
Track 03: Depression and Anxiety
Most people feel anxiety or depressed occasionally with Addiction. Losing a beloved, getting unemployed from a job, going through a divorce, and alternative troublesome things can lead an individual to feel unhappy, lonely, scared, nervous, or anxious. These feelings are normal reactions to lives under pressure. However some individuals experience these feelings daily or nearly daily for no apparent reason, creating it difficult to hold on with normal, everyday functioning. These individuals might have a mental disorder, depression, or both. Major depression may be a treatable malady that affects the approach an individual thinks, feels, behaves, and functions. At any point in time, three to five of individuals suffer from major depression; the time period risk is concerning terrorist organization 17%.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neuroradiology conference June 13-15, 2016 Rome, Italy, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 47th Addiction Medicine Conference June 14-17, 2016 Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine conferences June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, National Institute on Alcohol Abuse and Alcoholism, New York State Office of Alcoholism and Substance Abuse Services, Substance Abuse and Mental Health Services Administration, The Association For Addiction Professionals, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 04: Clinical Interventions
Recent clinical studies have shown that between half-hour and hour of drug abusers have mental state diagnoses Depression, schizophrenic psychosis, and manic disorders. Drug addiction may be a typical of disorder involves the interaction of environmental factors and genetic factors to extend the susceptibility of an individual to addictive behaviour. SAMHA scientist’s area unit working on the pharmacological and neuropsychosocial models and approaches that involve pre-symptomatic studies and clinical findings, to elucidate the results of mental health and physical disorders and outcomes in drug-addicts, Researchers specialize in pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioral therapies in smokers with synchronous psychiatrically disorders.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neuroradiology conference August 22-23, 2016 Vienna, Austria, Neuroinformatics Conference September 29-October 01, 2016 Valencia, Spain, Neurorehabilitation conference November 14-16, 2016 Dubai, UAE, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia. Academy Health Research Meeting June 26-28, 2015 Boston Massachusetts, Alcoholism and Substance Abuse Providers of New York State, National Institute on Drug Abuse, American Academy of Addiction Psychiatry, American Society of Addiction Medicine, Canadian Societies of Addiction Medicine, Dutch Society
Track 05: Dual Diagnosis
Dual diagnosis is the condition of suffering from an addictive disorder and a co-occurring misuse problem. Any patient will have a "dual diagnosis" associated for an addiction disorder will have a “co-occurring mental disorder”. Identification a primary psychiatrically sickness in substance abusers is difficult as drug abuse itself typically induces medical specialty issues, therefore creating it necessary to differentiate between drug iatrogenic and pre-existing psychopathy. Addiction treatment, as well as alcohol and prescribed drugs, will induce symptoms which resembles psychopathy.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine conferences June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Conference June 22-25, 2016 Melbourne, Australia, Drug Dependence Annual Meeting June 11-16, 2016 Palm Springs, California, USA, National Institute on Alcohol Abuse and Alcoholism, New York State Office of Alcoholism and Substance Abuse Services, Substance Abuse and Mental Health Services Administration, The Association For Addiction Professionals, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 06: Dual diagnosis treatment
Mental disorders with complications brought through alcohol or substance abuse. Dual diagnosis can be challenging to distinguish and diagnose because the use of medicine can often carry medical specialty symptoms that build it arduous to differentiate from a pre-existing disorder. Since this condition requires attention for abuse as well as psychopathy, a dual diagnosis scenario most frequently is additional complicated than these conditions independent diagnosed with Dual Diagnosis therapy area unit at a better risk for substance dependency of marijuana, opiates, and cocaine and alternative stimulants and alcohol and other people.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd CNS treatment conference December 01-02, 2016 Dubai, UAE, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine conferences June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, 9th Psychopharmacology Annual Conference June 12-16, 2016 Minneapolis, Minnesota, The American Society of Addiction Medicine Annual Conference June 14-17, 2016 Baltimore, Maryland, The Addiction Section of the Egyptian Psychiatric Association, Finnish Society of Addiction Medicine, Israeli Society of Addiction Medicine, Swiss Society of Addiction Medicine, Alcoholism and Substance Abuse Providers of New York State
Track 07: Drug addiction Pathophysiology
The biology of addiction treatment encompasses quite the neurochemistry of reward. The cortical region of the brain and underlying substantial Alba connections between the cortical region and circuits of reward, motivation and memory are basic within the manifestations of altered impulse management, altered judgment, and therefore the dysfunctional pursuit of rewards seen in addiction despite accumulative adverse consequences toughened from engagement in substance use and alternative habit-forming behaviours.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, Neuro Genetics conference June 06-07, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, Society of Behavioural Medicine 2016 July 30-June 2, 2016 Washington, DC, Alcoholism and Substance Abuse Providers of New York State, National Institute on Drug Abuse, American Academy of Addiction Psychiatry, American Society of Addiction Medicine, Canadian Societies of Addiction Medicine, Dutch Society
Track 08: Addiction therapy
Addiction treatment is meant to assist inveterate people stop compulsive drug seeking and use. Drug treatment will embrace behavioural medical aid like cognitive-behavioral medical aid or contingency management, medications. Behavioural therapies will facilitate encourage individuals to participate in drug treatment, provide ways for managing drug cravings, teach ways in which to avoid medicine and stop relapse, and facilitate people touch upon relapse if it happens.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd CNS treatment conference December 01-02, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, Community Anti-Drug Coalitions of America July 23-27, 2017 Atlanta, Georgia, American Academy of Addiction Psychiatry, American Association of Directors of Psychiatric Residency Training, Association for Academic Psychiatry, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 09: Addictive Disorders
Addictive disorder could be a medicine chronic destruction of brain reward system, motivation, and memory. Results in inability to regulate behaviour, results in habitual changes, and that affect someone from recovery of substance. Reason for habit-forming disorder is habit or activity that offers America pleasure and a genetic variance that will increase our interest. Addiction therapy is genetically developed in our psychological system, social and environmental factors that cause excessive and prolonged usage, tolerance and withdrawal and negative consequences.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14-17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1-2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, Correctional Health Care National Conference October 22-26, 2016 Las Vegas, Nevada, The Addiction Section of the Egyptian Psychiatric Association, Finnish Society of Addiction Medicine, Israeli Society of Addiction Medicine, Swiss Society of Addiction Medicine, Alcoholism and Substance Abuse Providers of New York State
Track 10: Science of Drug abuse
Drug abuse is over use drug wherever the user intakes the substance in Brooding again amount that is harmful. Alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, cannabis and opioids are usually used medication in abuse. Addiction rehabilitation approved for treatment is replacement therapies like buprenorphine and dolphin hydrochloride. Reports justify that forty three.7 million Americans ages fifteen seasoned mental state. Within the past year, 25.7 million adults had a substance use disorder. In those 8.4 million folks had each a disorder and substance use disorder, additionally referred to as co-occurring mental and drug use disorders.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd CNS treatment conference December 01-02, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Sleep Medicine conference November 28-30, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1 - 2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, American College of Psychiatrists Annual Meeting February 17-21, 2016Rio Grande, Puerto Rico, Alcoholism and Substance Abuse Providers of New York State, National Institute on Drug Abuse, American Academy of Addiction Psychiatry, American Society of Addiction Medicine, Canadian Societies of Addiction Medicine, Dutch Society
Track 11: Addiction Medicine
Addiction Treatment, such as methadone, buprenorphine, and naltrexone (including a new long-acting formulation), are available for individuals addicted to opioids, Drug dependence is associate degree adaptive state that results from continual drug usage, and which ends up in withdrawal upon stopping drug use. Dependency may be a totally different criterion from substance dependence, associate degree addictive, unconditional drug use, and results severe issues. Associate degree addictive drug will functions on appreciated and reinforcing systems.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Epilepsy conference September 21-22, 2015 Baltimore, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1 - 2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, Anti-Drug Coalitions of America 2016 February 1-4, 2016 National Harbor, Maryland, American Association for the Treatment of Opioid Dependence Conference October 29-November 2, 2016 Baltimore, Maryland, National Institute on Alcohol Abuse and Alcoholism, New York State Office of Alcoholism and Substance Abuse Services, Substance Abuse and Mental Health Services Administration, The Association For Addiction Professionals, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 12: Psychiatry & Mental Health
Psychiatry focuses on the diagnosing, treatment, and hindrance of psychological state and emotional issues. We will understand the body's functions and also the advanced relationship between emotional malady and alternative medical malady. Psychological state skilled and doc will distinguish between physical and psychological causes of each mental and physical disorders Scientist’s area unit developing interventions exploitation pharmacological and behavioral treatments in alcohol and chemical dependence and addiction rehabilitation.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neurorehabilitation conference November 14-16, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1 - 2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, 8th Addiction Conference February 10-12, 2016 Jackson, Mississippi, Europad Conference May 27-28, 2016, Leiden, the Netherlands, Community Anti-Drug Coalitions of America July 14-21, 2016 Las Vegas, Nevada, American Academy of Addiction Psychiatry, American Association of Directors of Psychiatric Residency Training, Association for Academic Psychiatry, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 13: Dual Diagnosis & Neuroimmune Function
According to American Association of Dual Diagnosis Alcohol and alternative medication of abuse have vital impacts on the neuroimmune system. Studies have incontestable that medication of abuse move with the Addiction Rehabilitation and alter neuroimmune organic phenomenon and signalling, that successively contribute to numerous aspects of addiction. Because the key part of the central nervous system. These neuromodulator properties of immune factors, alongside their essential role in neuroinflammation, give a replacement framework to know neuroimmune mechanisms mediating brain purposeful and activity changes tributary to addiction. This chapter highlights recent advances in understanding hard drug.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, 2nd Depression, Anxiety and Stress Management conference November 07-08, 2016 Barcelona, Spain, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, 18th Addiction Therapy conference July 1 - 2, 2016, Miami, USA, Addiction Medicine Conference June 22nd and 25th 2016 Asheville, USA, 8th Cognitive Behavioural Therapies Conference June 22-25, 2016 Melbourne, Australia, National Drug Summit July 28-31, 2016 Atlanta, Georgia, The Addiction Section of the Egyptian Psychiatric Association, Finnish Society of Addiction Medicine, Israeli Society of Addiction Medicine, Swiss Society of Addiction Medicine, Alcoholism and Substance Abuse Providers of New York State
Track 14: Dual Diagnosis & Self-medication
Self-medication is that the use of medication to treat self-diagnosed diseases and their symptoms, or the irregularities and continued use of a prescribed drug for chronic or continual malady or symptoms. Self-medication may be a human behaviour during which a personal uses a substance use or any exogenous influence to self-administer treatment for non-clinical physical or psychological ailments. The foremost wide self-medicated substances area unit Over-the-counter medicine and diet supplements. Self-medicating scientific discipline with mind-blowing medicine is mistreatment alcohol, food, and different sorts of behaviour to alleviate symptoms of distress in psychological state, anxiety & stress.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neurorehabilitation conference November 14-16, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, Meeting on Psychiatry September 07-09, 2016 Amsterdam, The Netherlands; WCSAD 2016 West Coast Symposium on Addictive Disorders June 2 - 5, 2016 California, USA; 2015 Cape Cod Symposium on Addictive Disorders September 08-11, 2016 Massachusetts, United States; Florida's Premier Behavioral Annual Health Conference August 5 - 7, 2015 Florida, USA; 2015 National Conference on Addiction Disorders and BH Leadership Summit Esteemed Faculty August 01-08, 2015 Missouri, USA; Innovations in Behavioral Healthcare June 22-23, 2015 Tennessee, USA, Alcoholism and Substance Abuse Providers of New York State, National Institute on Drug Abuse, American Academy of Addiction Psychiatry, American Society of Addiction Medicine, Canadian Societies of Addiction Medicine, Dutch Society
Track 15: Dual Diagnosis & Drug Legalization
Drugs legalization is useful for medical use of illicit medication. Medication normally thought of capable of recreational use embrace ethyl alcohol, cannabis, nicotine, caffeine, and substances among the scope of the United Nations' Single Convention on Narcotic medication. American Association of Dual Diagnosis, in 2012 it had been calculable that concerning third to six of individuals use non-legal medication. Hallucinogenic Substances Domestic and jurisprudence social control agencies square measure occupied with interdiction efforts against contraband drug use, production, and circulation. Narcotic use is use of a drug with the first intention to change the state of consciousness so as to make positive emotions.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neurorehabilitation conference November 14-16, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, The International Narcotics Research Conference (IRNC) 2015 June 15-19, 2015 Arizona, USA; Addiction 2015 - The Australian and New Zealand Addiction Conference Queensland, Australia; ICADD 2015 May 18-20 Idaho, USA; International Society of Addiction Medicine Congress 2015 Dundee City, Scotland; 2016 NAATP Conference Addiction Conferences Addiction Treatment May 15-17, 2016 Florida, United States, National Institute on Alcohol Abuse and Alcoholism, New York State Office of Alcoholism and Substance Abuse Services, Substance Abuse and Mental Health Services Administration, The Association For Addiction Professionals, Association for Medical Education and Research in Substance Abuse, American Medical Association
Track 16: Epidemiology of Dual disorders
American Association of Dual Diagnosis reveals to grasp the character and extent of white plague, drug abuse, dependence, and associated risk and protecting factors. Round the world, 17.3 million individuals have drug use disorders. Within the year 2012, around 3.3 million deaths, were known thanks to alcohol consumption. In 2008, 3.5% to 5.7% of the world's population aged 15-64, used non-prescribed psychedelic medication. Globally cannabis usage is seen in 129-190 million individuals, next is amphetamines, cocaine and opioids. In step with the yank Medical Association thirteen.5 capitalize on the U.S. population has a substance abuse Disorder.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neurorehabilitation conference July 21-22, 2016 Brisbane, Australia, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, International Conference on Neuro Informatics September 29-October 01, 2016 Valencia, Spain, 9th Annual Psychopharmacology Institute and ISPN 18th Annual Conference June 12-16, 2016 Minneapolis, Minnesota; The ASAM 47th Annual Conference - Innovations in Addiction Medicine and Science June 14 - 17, 2016 Baltimore, USA; The ASAM State of the Art Course in Addiction Medicine October 6-8, 2016 Washington, USA; The ASAM 48th Annual Conference Innovations in Addiction Medicine and Science June 6 - 9, 2017,New Orleans, USA; American Counselling Association (ACA) Annual Conference and Expo July 31-June 3, 2016, Montreal, Quebec, Canada, American Psychiatric Association, American Society of Addiction Medicine, Columbia University Gambling Disorder Clinic, International Society of Addiction Medicine, National Institute on Drug Abuse
Track 17: Dual Diagnosis Rehabilitation & Recovery
Drug rehabilitation could be a medical or Psychotherapeutic treatment of dependency for mind-bending substances like addictive medication, alcohol and fatal medication like amphetamines opiate and cocaine. The general committed is to alter the patient to stop drug abuse to avoid the monetary, legal, psychological, social, and consequences that effects physically. Dual Diagnosis treatment centres embody meditation and non-secular knowledge within the treatment method. Within the U.S.A, it's calculable that 25-40 million individuals square measure in recovery.
Related Dual Diagnosis Conferences | Addiction Conferences | Neuroscience Conferences
Dual Diagnosis conference July 18-19, 2016 Chicago, USA, 5th Addiction Therapy conference October 03-05, 2016 Florida, USA, Neurorehabilitation conference July 21-22, 2016 Dubai, UAE, 5th Alzheimer’s Disease and Dementia Conference September 29-October 01, 2016 London, UK, 2nd Brain Disorders Conference October 26-28, 2016 Chicago, USA, 47th Addiction Medicine Conference June 14 - 17, 2016 Hilton Baltimore, Baltimore, Australian and New Zealand Addiction Conference May 18-20 2016 Gold Coast, Australia, Unite to Face Addiction October 4, 2015 Washington, USA; Foundations Recovery Network – Moments of Change September 28- October 01, 2015 Florida, USA; Inner Peace Yoga Therapy June 11–June 24, 2016 Texas, USA; Innovations in Recovery Conference July 30- Apr 2015 California, USA; Symposium on Yoga Therapy and Research June 04-07, California, USA, American Academy of Addiction Psychiatry, American Association of Directors of Psychiatric Residency Training, Association for Academic Psychiatry, Association for Medical Education and Research in Substance Abuse, American Medical Association
Dual diagnosis 2016 welcomes Researchers, Scientists, Students and exhibitors from all over the world to Chicago, USA. We are gratified to invite you all to attend and register for the “International Conference and Exhibition on Dual Diagnosis ” which is going to be held during July 18-19, 2016 in Chicago, USA.
The organizing committee is planning a conference program including plenary speech, symposiums, workshops, poster presentations and various programs for participants throughout the world. We invite you to join us at the Dual Diagnosis 2016, where you will definitely have profound experience with researchers globally. All the members of Dual Diagnosis 2016 organizing committee are pleasure to meet you in Chicago, USA.
Importance and Scope:
In USA, specialist mental health settings grew by 61% between 2010 and 2014. USA mental health system, 29% of state and territory mental health spending was dedicated to caring for people in the community by 2014, the share of total mental health expenditure had increased to 53%.
In 2011 USA National Survey on Drug Use and Health stated that 18.5% of adults with mental illness had a co-occurring substance use disorders, effects 9.98 million people. According to the Drug Abuse, Alcohol, and Mental Health Administration, 60 % of the 2 million populations with severe mental illness addicted to drugs or alcohol, compared to 15 % of the general population. Americans 17 million adults have alcohol use disorders, either alcoholism or other, problems. The cost of those problems to the nation’s economy is $185 billion annually.
UK studies have shown slightly more potent rates of substance misuse among mentally ill persons. Individuals suffering from schizophrenia showed just a 7% prevalence of problematic drug use in the year prior to being interviewed and 21% reported misuse.
In Europe, SAMHSA report shows that 34.6 million adults aged 18 taken mental health treatments or counselling during the past 12 months. Nearly 43.8 million identified cases in mental illness in 2015.
Why in Chicago, USA?
Chicago is the third most populous city in the United States. With over 2.7 million residents, it is the most populous city in the state of Illinois and the Midwest. The Chicago metropolitan area, often referred to as Chicago land, is home to nearly 10 million people and is the third-largest in the U.S.A.
The increase in the numbers of heroin-related deaths from 2011 to 2012 in the suburban counties around Chicago was the most important finding for the Chicago area for this reporting period. The increases in heroin-related deaths were observed in the suburban Chicago counties of DuPage, Lake, Will, McHenry, and Kane. Epidemiological indicators suggested that heroin, cocaine, and marijuana, cannabis continued to be the most common illicit substances appearing in drug indicators in Chicago during this reporting period. These were also the drugs that were most frequently identified among drug reports from items seized by law enforcement and analysed in National Forensic Laboratory Information System forensic laboratories in the first half of 2013. They accounted for 76 percent of all drug reports among drug items seized and analysed.
Statistically, 8.3 million or 55% of USA people aged 16-85 will experience mental health condition like depression, anxiety or drug addiction, according to the 2009 National Institute of Drug Abuse. Second National Survey of Psychosis conducted in March 2010 suggests almost 64,000 people have a psychotic illness and are in contact with public specialised mental health services.
The Government will give $40.0 million in 2015-16 to drug addiction, social and mental health services in some drought affected communities. Last year, the Government froze indexation across 78 government programmes, including a range of drug abuse. This budget extends until the end of 2019-20. The Health Portfolio Budget Statement also reveals that approximately $34 million less will be spent on drug addiction and mental health services over four years than the Government forecast at this time.
Conference Highlights:
Addiction Medicine
Clinical Aspects & Case Studies
Dual Diagnosis
Drug Addiction Pathophysiology
Drug Addiction and Neurotoxicology
Addiction Therapy
Addictive Disorders
Science of Drug abuse
Addiction Psychiatry
Neuroimmune Function
Self-medication
Drug Legalization
Addiction Rehabilitation and Recovery
Epidemiology of Addiction
Why to attend???
Dual Diagnosis 2016 will provide an opportunity for all stakeholders working on Drug addiction and co-occurring psychiatric disorders to talk about their work. Dual Diagnosis 2016 will congregate renowned speakers, principal investigators, experts, neurologist’s and Drug addiction and Psychiatry researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Drug addiction, mental health and Neurology.
Members Associated with Dual Diagnosis:
Around 8 associations of Dual Diagnosis are there in Chicago:
American Society of Addiction Medicine (ASAM)
Substance Abuse and Mental Health Services Administration
Georgia Addiction Counsellors Association (GACA)
National Survey on Drug Use and Health (NSDUH)
National Addiction Studies Accreditation Commission (NASAC)
National Mental Health Services (NMHS)
Societies and Associations:
Around 25 associations of Dual Diagnosis are there in USA:
American Academy of Addiction Psychiatry
American Association of Directors of Psychiatric Residency Training
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Mental Health and Addiction (DMHA) Bureau of Mental Health Promotion
Association for Addiction Professionals (NAADAC)
National Opioid Pharmacotherapy Statistics Annual Data Collection (NOPSAD)
Association for Academic Psychiatry
Around 200 associations of Dual Diagnosis are there globally:
National institute of drug abuse
Centre for Addiction and Mental Health
SAMHSA substance abuse and mental health society’s administration
American Society of Addiction Medicine
CASA Columbia ending addiction changes
MHA mental health America
American Society of Addiction Medicine
NDARC national drug alcohol research centre
Target Audience:
Directors, neurologist, neurosurgeons, psychiatrist, head of department, Professors and Students from Academia in the research of Drug Addiction and Co-occurring Mental disorders.
Target Audience:
Academia 70%
Industry 20%
Others 10%
Top Universities 50 in USA working in the field of Dual Diagnosis:
The American Addiction and Trauma Treatment Centre
University of Chicago
RMIT University
The Psychological society
Victoria University Melbourne Australia
Swine Burn university of technology
Monash University
Top universities 300 globally working in the field of Dual Diagnosis:
University of Detroit Mercy in Detroit, MI
University of pacific in Stockton, CA
East California University
New York Institute of Technology in Westbury, NY
Portland Community College
Southern University at New Orleans
Mercy College
University of California-San Diego
University of Cincinnati
University of phoenix
Walden University
North central university
Grand Canyon University
Southern New Hampshire University
Herding University
Azusa pacific university college
Boston College (BC) in Massachusetts
University of Wisconsin (UW) – Madison
Clemson University
The George Washington University
Johns Hopkins University
Marquette University
Pennsylvania State University
St. John's University
University at Buffalo
University of Wisconsin
Western Michigan University
Hospitals Associated with Dual Diagnosis Research
There are 30 hospitals working on Dual Diagnosis in Chicago:
Rush university Medical Centre
Loretto Hospital
Alexian brother’s behavioural health hospital
Atlantic Shores Hospital
Provena Mercy Medical Centre
There are 200 hospitals working on Dual Diagnosis in USA:
Victorian Government health Information
Glenside health Services
Pine Rivers private hospitals
The Chicago Clinic
St John of God Warnambool Hospital
Millbrook Rise Hospital for Mental Health
Drug and Alcohol Rehabilitation.
Malvern Private Hospital
All around the globe there are 2000 hospitals working on Dual Diagnosis:
Adcare Hospitals
Highland Ridge hospital
Seven Hills Behavioural institute
Sharp Mesa Vista Hospital
Edward Hospital and Health services
The priory Hospital North London
Castle Craig Hospital
T.T. Ramanathan clinical Research Foundation
Industries Associated with Dual Diagnosis Research
Industries Associated with Dual Diagnosis Research In Chicago:
Aspen America
Alphapharm
AstraZeneca
Apotex
Vincent Chemical Co
Industries Associated with Dual Diagnosis Research In USA:
Herron Pharmaceuticals
Sigma Pharmaceuticals
American Drug Testing
Giaconda pharmaceutical company
Lawley Pharmaceuticals
Jasol Chemical Products
Industries Associated with Dual Diagnosis Research Globally
Sanofi-aventis
GlaxoSmithKline
Merck Sharp & Dohme
Sandoz
Boehringer Ingelheim
Eli Lilly
Abbott Laboratories
Roche
Novartis
Johnson & Johnson
Market analysis:
The 2014 USA National Survey on Drug Use and Health announced that 17.5% of adults with a mental illness had a co-occurring substance use disorder. This affects 7.98 million people in USA. Estimation of psychiatric disorders in Canada is very high, with an estimated 40-60% of adults with severe mental illness experiencing a substance use disorder in their life. A survey in the United States attempting to assess the prevalence of dual diagnosis found that 77% of clients with schizophrenia had a substance misuse disorder in their life.
In Australia, extent of substance misuse of 30% chronically mentally ill patients. Clinical trials reveals, around a third of the population effected with drug addiction leads to mental illness.
UK studies have shown slightly high rate of substance misuse among mentally ill persons. Research states that individuals suffering from schizophrenia showed just a 7% prevalence of problematic drug use.
In London, over the previous 6 months cases of alcohol or substance misuse and dependence were identified by clinical trials. The prevalence rates of dual diagnosis were 33% for the use of any substance, 40% for alcohol misuse and 15% for drug misuse. Any illicit drug use was observed in 35% of the sample. In 2012, only 15.4% of Americans with co-occurring disorders were receiving both mental health and addictions treatment.
The World Drugs report for 2014 states 230 million people from the world 1 in 20 of us took abuse drugs. The report says that problem drug users, mainly heroin - and cocaine-dependent people number about 27 million, nearly 0.6% of the world adult population. That's 1 in every 200 people. In Australia in 2010–15, 52 government-funded alcohol and other drug treatment agencies provided 17,187 treatment services. An increase of eight treatment agencies and 272 treatment episodes compared with 2008–09. The median ages of persons receiving treatment for their therapeutic use for normal diseases in 2008–09. Alcohol (49%), cannabis (19%) and amphetamines (14%) were again the top three drugs. As in 2008–09, counselling was the most common form of main treatment provided (63%), followed by withdrawal management (8%), rehabilitation and information and education (6%).
Funding’s for dual diagnosis:
The Substance Abuse Prevention and Treatment Block Grant (approximately $62.6 million) is a major funder of addiction prevention and treatment services in Ohio. The Community Mental Health Block Grant (approximately $34 million) provides funding to ADAMH/CMH (Alcohol, Drug Addiction and Mental Health/Community Mental Health) Boards for recovery supports, as well as treatment services for low income persons without Medication or other insurance. Navajo Regional Behavioural Health Centre provides (nearly $28 million) provided funding for Drug addiction cases. National Survey on Drug Use and Health (NSDUH) provided funds nearly $22 million for co-occurring mental disorders treatment.
Products:
|
Drugs
|
Pharmaceutical Company
|
Global Sales
|
|
Avinza®
|
Pfizer Inc.
|
$ 11 million
|
|
Butrans®
|
Purdue Pharma L.P.
|
$20.5 million
|
|
Dolophine®
|
Roxane Laboratories, Inc
|
$13.5 million
|
|
Duragesic®
|
Janssen Pharmaceuticals
|
$7 million
|
|
Embeda®
|
Pfizer Inc.
|
$ 9 million
|
|
EXALGO®
|
Mallinckrodt
|
$20.2 million
|
|
MS Contin®
|
Purdue Pharma L.P
|
$29.1 million
|
|
Nucynta® ER
|
Endo Pharmaceuticals Inc
|
$17 million
|
|
Zohydro® ER
|
Pernix Therapeutics
|
$13 million
|
|
Astramorph
|
APP Pharmaceuticals
|
$12 million
|
References:
1. http://edhelper.com/ReadingComprehension_29_92.html
2. http://www.medicinenet.com/drug_abuse/page2.htm
3. http://www.thegooddrugsguide.com/addiction-types/drug-addiction/index.htm
4. http://www.webmd.com/mental-health/addiction/substance-abuse
5. http://www.thegooddrugsguide.com/addiction-types/index.htm
